Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cresco Labs (CRLBF) Shares Outstanding (Diluted Average) (2019 - 2023)

Historic Shares Outstanding (Diluted Average) for Cresco Labs (CRLBF) over the last 4 years, with Q4 2023 value amounting to $323.8 million.

  • Cresco Labs' Shares Outstanding (Diluted Average) changed N/A to $323.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was $323.8 million, marking a year-over-year change of. This contributed to the annual value of $323.8 million for FY2023, which is N/A changed from last year.
  • As of Q4 2023, Cresco Labs' Shares Outstanding (Diluted Average) stood at $323.8 million.
  • Cresco Labs' 5-year Shares Outstanding (Diluted Average) high stood at $323.8 million for Q4 2023, and its period low was $230.0 during Q3 2020.
  • Its 4-year average for Shares Outstanding (Diluted Average) is $64.8 million, with a median of $390.0 in 2020.
  • As far as peak fluctuations go, Cresco Labs' Shares Outstanding (Diluted Average) surged by 540.54% in 2020, and later surged by 41739.13% in 2021.
  • Cresco Labs' Shares Outstanding (Diluted Average) (Quarter) stood at $370.0 in 2019, then rose by 5.41% to $390.0 in 2020, then skyrocketed by 205.13% to $1190.0 in 2021, then surged by 27211645.04% to $323.8 million in 2023.
  • Its Shares Outstanding (Diluted Average) stands at $323.8 million for Q4 2023, versus $1190.0 for Q3 2021 and $390.0 for Q4 2020.